OneSkin Technologies
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
OneSkin Technologies - overview
Established
2016
Location
San Francisco, CA, US
Primary Industry
Biotechnology
About
OneSkin Technologies is dedicated to developing innovative skincare solutions leveraging biotechnology to promote healthy skin aging. The company focuses on creating advanced products to improve skin resilience and appearance. Founded in 2016, OneSkin Technologies is a biotechnology company based in San Francisco, US, specializing in skincare solutions that utilize groundbreaking technological advancements. The company has undergone no significant pivots since its inception.
The latest funding round, Series A, raised USD 7. 00 mn, led by Selva Ventures, with participation from investors including Unilever Ventures and others. OneSkin has completed a total of 4 deals to date. OneSkin Technologies offers a range of innovative skincare products that utilize advanced biotechnology to target skin health and aging.
Their flagship offerings focus on enhancing skin resilience and appearance through scientifically developed formulations. The company also provides consulting services to assist clients in maximizing their skincare investments. Their products are marketed extensively across North America, Europe, and Asia, catering to a diverse clientele from small businesses to large corporations. OneSkin Technologies generates revenue primarily through a subscription-based model, allowing customers to access their skincare solutions on a recurring basis with annual agreements.
This model ensures continuous product access along with regular updates and support. The pricing structure is designed to accommodate various client needs, thereby enhancing client retention. Additionally, the company engages in direct sales of specialized packages to individual consumers, promoting a personalized approach to skincare solutions. OneSkin Technologies plans to leverage its recent funding from Metaplanet Holdings to expand its product line with new formulations aimed at specific skincare concerns, with launches expected in the upcoming fiscal year.
The company is also targeting expansion into new markets in Asia and Europe by 2025, aiming to capture a broader international customer base. The funding will support research and development efforts as well as marketing initiatives to facilitate this growth. In August 2025, Prelude Growth Partners invested USD 20 million in OneSkin Technologies.
Current Investors
Prelude Growth Partners, SOSV, IndieBio
Primary Industry
Biotechnology
Sub Industries
Biopolymers, Molecular Science, Genetics & Gene Therapy, Healthcare IT
Website
www.oneskintechnologies.com
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
OneSkin Technologies - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | OneSkin Technologies | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.